SCHEMBL7272079

SCHEMBL7272079

O=C(NC1CCc2ccccc2C1=O)c1ccccc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.80
RAB9A P51151 1/20 0.80
SMN1; SMN2 Q16637 1/20 0.80
DDB1 Q16531 1/20 0.56
CRBN Q96SW2 1/20 0.56
HTT P42858 1/20 0.56
ALDH1A1 P00352 2/20 0.51
MAPK14 Q16539 1/20 0.46
SRD5A1 P18405 1/20 0.45
SRD5A2 P31213 1/20 0.45
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
LMNA P02545 2/20 0.45
KMT2A Q03164 1/20 0.45
PYGL P06737 1/20 0.44
PYGM P11217 1/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10485188 0.89 SMN1; SMN2 (0.77) NPC1RAB9ASMN1; SMN2DDB1CRBN
SCHEMBL30721496 0.82 NPC1 (0.67) NPC1RAB9ASMN1; SMN2ALDH1A1MTNR1A
SCHEMBL697728 0.82 NPC1 (0.67) NPC1RAB9ASMN1; SMN2ALDH1A1MTNR1A
SCHEMBL3460628 0.80 HTT (0.83) HTTALDH1A1LMNAKMT2APDE4A
SCHEMBL3459886 0.80 HTT (0.83) HTTALDH1A1LMNAKMT2APDE4A
SCHEMBL2465110 0.80 HTT (0.83) HTTALDH1A1LMNAKMT2APDE4A
SCHEMBL29742388 0.80 HTT (0.83) HTTALDH1A1LMNAKMT2APDE4A
SCHEMBL6634651 0.79 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2CRBNALDH1A1
SCHEMBL695898 0.78 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2ALDH1A1MTNR1A
SCHEMBL10394613 0.78 SMN1; SMN2 (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4420480-A PARKINSONISM, DEPRESSION, HYPOTENSIVES MERCK & CO., INC. (US) 1983-12-13 US disclosed
EP-0080115-A2 Hexahydronaphth(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical formulation containing them MERCK & CO. INC. (US) 1983-06-01 EP disclosed